Clinical and metabolic factors associated with chronic low-grade inflammation in type 2 diabetic patients

Código QR

Clinical and metabolic factors associated with chronic low-grade inflammation in type 2 diabetic patients

Aim. To identify the clinical and metabolic factors associated with serum concentration of high sensitivity C-reactive protein (hsCRP) and α1-acid glycoprotein (α1-AGP) in patients with type 2 diabetes.Material and methods. The study involved 210 patients with type 2 diabetes. Levels of hsCRP and α1...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vadim V. Klimontov, Nadezda V. Tyan, Olga N. Fazullina, Natalia E. Myakina, Alexander P. Lykov, Vladimir I. Konenkov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	diabetes obesity inflammation glucose variability acute-phase proteins Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/da1faa5c7f264d11ad42e1e80250f4ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
por: Vadim V. Klimontov, et al.
Publicado: (2015)

Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
por: Vadim V. Klimontov
Publicado: (2018)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
por: Vadim V. Klimontov, et al.
Publicado: (2016)

Risk factors for decreased bone mineral density in men with type 2 diabetes.
por: Olga N. Fazullina, et al.
Publicado: (2021)

Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue
por: Vadim V. Klimontov, et al.
Publicado: (2019)

The relationship of total body composition with bone mineral density in postmenopausal women with type 2 diabetes
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2015)

Associations of polymorphisms in the gene promoters of cytokines and matrix metalloproteinases with bone mineral density in postmenopausal type 2 diabetic women
por: Olga N. Fazullina, et al.
Publicado: (2018)

Vasculogenesis and angiogenesis in diabetes mellitus: novel pathogenetic concepts for treatment of vascular complications
por: Vladimir Iosifovich Konenkov, et al.
Publicado: (2012)

The role of comorbid hypertriglyceridemia and abdominal obesity in the severity of acute pancreatitis: a retrospective study
por: Xiaoxi Yang, et al.
Publicado: (2021)

Heart rate variability in male patients with metabolic syndrome
por: Andrey Evgen'evich Kratnov, et al.
Publicado: (2013)

Possibilities of metabolic surgery for the treatment of type 2 diabetes mellitus in patients with grade 1 alimentary obesity
por: Vladimir V. Salukhov, et al.
Publicado: (2018)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Cystatin C and collagen type IV in diagnostics of chronic kidney disease in type 2 diabetic patients
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2015)

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes
por: Alena V. Tiselko, et al.
Publicado: (2019)

1,5-anhydroglucitol in diabetes: its role in diagnostics, screening, glycemic status assessment, and the prediction of complications
por: V. V. Klimontov, et al.
Publicado: (2020)

Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
por: Vadim V. Klimontov, et al.
Publicado: (2019)

Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
por: Mikhail B. Antsiferov, et al.
Publicado: (2019)

Clinical and psychological aspects of hypoglycemia in patients with diabetes mellitus
por: Olga Georgievna Mel'nikova, et al.
Publicado: (2010)

Relationship of hypoglycemia and glucose variability with autonomic dysfunction in children and adolescents with type 1 diabetes
por: Dmitriy Nikitich Laptev
Publicado: (2014)

Melatonin and diabetes: from pathophysiology to the treatment perspectives
por: Vladimir Iosifovich Konenkov, et al.
Publicado: (2013)

Genetic and cellular techniques emerge as promising modalities for the treatment of diabetic foot syndrome
por: Vladimir Iosifovich Konenkov, et al.
Publicado: (2014)

Lipid profile and markers of vascular inflammation in patients with stable angina in the presence and absence of type 2 diabetes mellitus
por: Tatiana I. Petelina, et al.
Publicado: (2017)

Time in range is a tool for assessing the quality of glycemic control in diabetes
por: L. A. Suplotova, et al.
Publicado: (2021)

Prevalence of type 2 diabetes mellitus and other abnormalities of carbohydrate metabolism depending on diagnostic criteria
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

The dynamics of invasive and noninvasive blood glucose monitoring methods: Recent trends
por: Alina Yur'evna Babenko, et al.
Publicado: (2016)

Associations of vascular endothelial growth factor (VEGF) gene and cytokine (IL-1B, IL-4, IL-6, IL-10, TNFA) genes combinations with type 2 diabetes mellitus in women
por: Vladimir Iosifovich Konenkov, et al.
Publicado: (2012)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

The role of CD40 receptor-ligand system in the development of diabetes mellitus and its complications
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Some mechanisms of inflammation development in type 2 diabetes mellitus
por: L. A. Bochkareva, et al.
Publicado: (2021)

N-acetylcysteine supplementation did not reverse mitochondrial oxidative stress, apoptosis, and inflammation in the salivary glands of hyperglycemic rats
por: Zalewska Anna, et al.
Publicado: (2021)

Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
por: Alina Babenko, et al.
Publicado: (2014)

The 3d World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, Prague, 13-16 May 2010
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010)

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

Carbohydrate metabolism in menopausal women
por: Olga Rafael'evna Grigoryan, et al.
Publicado: (2009)

Comments to: ?Type 2 diabetes mellitus ? time to change the concept?
por: Oleg Viktorovich Udovichenko
Publicado: (2014)

The 5th International Conference on Advanced Technologies Treatments for Diabetes (ATTD 2012),2012 February 8-11, Barcelona (Spain)
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)